ColumbiaDoctors Eastside and Columbia University Medical Center are announcing the creation of a specialized medical center dedicated to blood cancers, the Center for Lymphoid Malignancies.
The Center for Lymphoid Malignancies will feature over 25 physicians, nurses, clinical trial coordinators, regulatory specialists, laboratory scientists, and staff. Their sole focus will be on lymphoid cancers (a term that includes lymphoma and leukemia), and many of these renowned professionals have been working together for many years.
Owen A. O'Connor, MD., Ph.D. will serve as the Director. The Center for Lymphoid Malignancies will offer:
-- A group of physicians highly-skilled and experienced in managing patients with all forms of lymphoid cancers, including all subtypes of non-Hodgkin's lymphoma, Hodgkin's Disease, chronic lymphocytic leukemia (CLL), and acute lymphoblastic leukemia/lymphoma (ALL),
-- While focused on patients with lymphoid malignancies, the physicians also bring an expertise in most blood related cancers, including multiple myeloma, myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML).
-- A portfolio of nearly 20 Phase 1, 2 and 3 clinical trials offering some of the newest treatments available for these diseases. This portfolio of clinical studies devoted to lymphoid malignancies is among the largest in the country.
-- Highly skilled nursing care, including nurses with experience from the most prominent cancer centers in the country, capable of helping patients navigate the complexities of an unusual disease, and its treatment.
-- Skilled psychiatric and psychosocial support for patients.
Source: MarketWatch